Federal Enforcement Strenghtens Compliance in Medicare Advantage
Efforts to address fraud, waste, and abuse in healthcare continue to be a major focus for federal enforcement, particularly within the growing Medicare Advantage (MA) sector.
As Medicare Advantage (MA) programs expand, so does federal scrutiny. Both the Department of Justice (DOJ) and Congress are intensifying their oversight, particularly through enhanced investigations and potential legislation aimed at Medicare Advantage Organizations (MAOs) and downstream providers. The Centers for Medicare & Medicaid Services (CMS) is also increasing its audit capabilities, strategically managing a backlog in Risk Adjustment Data Validation (RADV) audits and implementing new models for traditional Medicare. This heightened scrutiny is especially relevant for insurance professionals, given the compliance challenges and financial risks involved.
Historical Context and Legislative Developments
Since the inception of the MA program in 1997, enforcement actions for fraud under the False Claims Act (FCA) have steadily increased. Emerging theories suggest that some MAOs have overstated patient conditions to inflate risk scores—a strategy also seen in traditional Medicare. FCA settlements with MAOs have reached nearly $1 billion since 2010, highlighting the financial stakes involved. Meanwhile, Congress remains actively involved, with recent proposals like Senate Bill 1105 seeking to refine risk adjustment practices and curb risk score "gaming."
The Role of Audits and AI in Compliance
In a landmark development, CMS’s 2023 RADV final rule faces legal challenges, but the agency continues to expand its auditing efforts. By 2026, plans to increase audits from 60 to 550 contracts annually aim to address payment inaccuracies. Simultaneously, AI technologies, although encouraged for fraud prevention, face criticism when used for care denials. This scrutiny adds another layer of complexity for insurers adapting to regulatory expectations.
Impact of Regulatory Enforcement
Regulatory actions extend beyond MAOs to include brokers and agents. A recent court ruling upended restrictions on administrative payment caps, suggesting potential shifts in future rulemaking. Moreover, bipartisan congressional efforts push for tighter consumer protections amid rising complaints about misleading MA marketing practices. Such developments place additional compliance burdens on industry stakeholders, who must navigate these evolving legal landscapes.
Anti-Kickback Statute and Financial Implications
Enforcement under the Anti-Kickback Statute (AKS) remains robust, as evidenced by significant settlements like MCS Advantage's $4.2 million and Oak Street Health's $60 million for unethical inducements. These cases underscore the financial and reputational risks associated with non-compliance. As DOJ and HHS collaborate through a newly formed FCA Working Group, cross-agency efforts promise more efficient enforcement against MA program violations.
Navigating the Future
For insurance professionals, this dynamic environment requires a judicious balancing act. Stakeholders must develop robust compliance mechanisms to align with federal expectations while levering emerging technologies wisely. Remaining vigilant about regulatory developments and adaptive in operations is crucial to thriving amid ongoing legal challenges and heightened enforcement.